摘要
目的探讨治疗急性重症脑血管病时应用醒脑注射液的临床效果。方法随机将收治的50例患有急性重症脑血管病的患者分为对照组和观察组,每组均为25例。对照组采用临床常规方法实施,观察组在常规治疗的基础上加以醒脑静注射液实施治疗。对比观察2组的治疗效果和不良反应发生情况。结果观察组总有效率88.0%,对照组总有效率56.0%,总有效率比较差异具有统计学意义(P<0.05);两组的不良反应发生情况分析,观察组的不良反应发生率低于对照组,差异具有统计学意义(P<0.05)。结论醒脑静注射液在治疗急性重症脑血管病时具有较好的临床效果,可以明显降低不良反应发生率,值得推广应用。
Objective To investigate the clinical effect of Xingnao injection in treatment of acute severe cerebrovascular disease.Methods Selecting 50 cases of patients with acute severe cerebral vascular disease, they were randomly divided into control group and observation group, with 25 cases in each group. The control group used routine clinical methods. The observation group was given additionally Xingnaojing injection. The therapeutic effect and adverse reaction of the two groups were compared. Results The total effective rate of the observation group and the control group was 88 % and 56%, respectively, and the difference was statistically significant（P〈0.05）. The adverse reactions of the observation group were lower than those the control group, and the difference was statistically significant（ P〈0.05）. Conclusion Xingnaojing injection in the treatment of acute severe cerebrovascular disease has good clinical effect, can significantly reduce the incidence of adverse reactions, and it is worthy of popularization and application.
出处
《中国中医药现代远程教育》
2016年第3期130-132,共3页
Chinese Medicine Modern Distance Education of China
关键词
急性重症脑血管病
醒脑静注射液
中风
acute severe cerebrovascular disease
Xingnaojing injection
stroke
